{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:28:01Z","timestamp":1759411681873},"reference-count":59,"publisher":"Japanese Association of Virology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2222\/jsv.68.125","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:06:49Z","timestamp":1600207609000},"page":"125-136","source":"Crossref","is-referenced-by-count":2,"title":["Future perspectives of mumps vaccine"],"prefix":"10.2222","volume":"68","author":[{"given":"Minoru","family":"KIDOKORO","sequence":"first","affiliation":[{"name":"Department of Virology III, National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Adams MJ, Lefkowitz EJ, King AMQ, Harrach B, Harrison RL, Knowles NJ, Kropinski AM, Krupovic M, Kuhn JH, Mushegian AR, et al: Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch Virol, 162:2505-2538, 2017.","DOI":"10.1007\/s00705-017-3358-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Elango N, Varsanyi TM, Kovamees J, Norrby E: Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol, 69 ( Pt 11): 2893-2900, 1988.","DOI":"10.1099\/0022-1317-69-11-2893"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kubota M, Takeuchi K, Watanabe S, Ohno S, Matsuoka R, Kohda D, Nakakita SI, Hiramatsu H, Suzuki Y, Nakayama T, Terada T, Shimizu K,Shimizu N, Shiroishi M, Yanagi Y, Hashiguchi T: Trisaccharide containing alpha2, 3-linked sialic acid is a receptor for mumps virus. Proc Natl Acad Sci U S A, 113:11579-11584, 2016.","DOI":"10.1073\/pnas.1608383113"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hosaka Y, Kuroda K, Ikeura A, Iwamoto T, Suzuki Y: Binding of influenza and paramyxoviruses to Group B Streptococcus with the terminal sialyl-galactose linkage. J Electron Microsc (Tokyo), 47:169-174, 1998.","DOI":"10.1093\/oxfordjournals.jmicro.a023574"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Santos-Lopez G, Scior T, Borraz-Arguello Mdel T, Vallejo-Ruiz V, Herrera-Camacho I, Tapia-Ramirez J, Reyes-Leyva J: Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. Braz J Infect Dis, 13:24-34, 2009.","DOI":"10.1590\/S1413-86702009000100007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tanabayashi K, Takeuchi K, Okazaki K, Hishiyama M, Yamada A: Identification of an amino acid that defines the fusogenicity of mumps virus. J Virol, 67:2928-2931, 1993.","DOI":"10.1128\/JVI.67.5.2928-2931.1993"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Adu-Gyamfi E, Kim LS, Jardetzky TS, Lamb RA: Flexibility of the Head-Stalk Linker Domain of Paramyxovirus HN Glycoprotein Is Essential for Triggering Virus Fusion. J Virol, 90:9172-9181, 2016.","DOI":"10.1128\/JVI.01187-16"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Orvell C, Alsheikhly AR, Kalantari M, Johansson B: Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol, 78 ( Pt 12): 3187-3193, 1997.","DOI":"10.1099\/0022-1317-78-12-3187"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kovamees J, Rydbeck R, Orvell C, Norrby E: Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res, 17:119-129, 1990.","DOI":"10.1016\/0168-1702(90)90073-K"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cusi MG, Fischer S, Sedlmeier R, Valassina M, Valensin PE, Donati M, Neubert WJ: Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res, 74:133-137, 2001.","DOI":"10.1016\/S0168-1702(00)00254-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, Kumagai T, Sakiyama H, Miyata A, Ochiai H, et al: Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol, 73:97-104, 2004.","DOI":"10.1002\/jmv.20065"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K: Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine, 24:2662-2668, 2006.","DOI":"10.1016\/j.vaccine.2005.10.050"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A: Variations of nucleotide sequences and transcription of the SH gene among mumps virus strains. Virology, 181:364-366, 1991.","DOI":"10.1016\/0042-6822(91)90504-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jin L, Rima B, Brown D, Orvell C, Tecle T, Afzal M, Uchida K, Nakayama T, Song JW, Kang C, et al: Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol, 150:1903-1909, 2005.","DOI":"10.1007\/s00705-005-0563-4"},{"key":"15","unstructured":"15) WHO: Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec, 87:217-224, 2012."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Cui A, Myers R, Xu W, Jin L: Analysis of the genetic variability of the mumps SH gene in viruses circulating in the UK between 1996 and 2005. Infect Genet Evol, 9:71-80, 2009.","DOI":"10.1016\/j.meegid.2008.10.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kidokoro M, Tuul R, Komase K, Nymadawa P: Characterization of mumps viruses circulating in Mongolia: identification of a novel cluster of genotype H. J Clin Microbiol, 49:1917-1925, 2011.","DOI":"10.1128\/JCM.02387-10"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Drexler JF, Corman VM, Muller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Cottontail VM, Rasche A, Yordanov S, et al: Bats host major mammalian paramyxoviruses. Nat Commun, 3:796, 2012.","DOI":"10.1038\/ncomms1796"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Katoh H, Kubota T, Ihara T, Maeda K, Takeda M, Kidokoro M: Cross-Neutralization between Human and African Bat Mumps Viruses. Emerg Infect Dis, 22:703-706, 2016.","DOI":"10.3201\/eid2204.151116"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kruger N, Sauder C, Huttl S, Papies J, Voigt K, Herrler G, Hardes K, Steinmetzer T, Orvell C, Drexler JF, et al: Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus. Cell Rep, 25:312-320 e317, 2018.","DOI":"10.1016\/j.celrep.2018.09.018"},{"key":"21","doi-asserted-by":"crossref","unstructured":"24) Hashimoto H, Fujioka M, Kinumaki H, Kinki Ambulatory Pediatrics Study G: An office-based prospective study of deafness in mumps. Pediatr Infect Dis J, 28:173-175, 2009.","DOI":"10.1097\/INF.0b013e31818a8ca8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"26) Everberg G: Deafness following mumps. Acta Otolaryngol, 48:397-403, 1957.","DOI":"10.3109\/00016485709126900"},{"key":"23","doi-asserted-by":"crossref","unstructured":"27) Kawashima Y, Ihara K, Nakamura M, Nakashima T, Fukuda S, Kitamura K: Epidemiological study of mumps deafness in Japan. Auris Nasus Larynx, 32: 125-128, 2005.","DOI":"10.1016\/j.anl.2005.01.009"},{"key":"24","doi-asserted-by":"crossref","unstructured":"37) Yoshida N, Fujino M, Ota Y, Notomi T, Nakayama T: Simple differentiation method of mumps Hoshino vaccine strain from wild strains by reverse transcription loop-mediated isothermal amplification (RT-LAMP). Vaccine, 25:1281-1286, 2007.","DOI":"10.1016\/j.vaccine.2006.09.093"},{"key":"25","doi-asserted-by":"crossref","unstructured":"38) Kuba Y, Kyan H, Arakaki E, Takara T, Kato T, Okano S, Oshiro Y, Kudaka J, Kidokoro M: Molecular Epidemiological Study of Mumps Epidemics of 2015 in Okinawa, Japan. Jpn J Infect Dis, 70:329-332, 2017.","DOI":"10.7883\/yoken.JJID.2016.390"},{"key":"26","doi-asserted-by":"crossref","unstructured":"39) Enders JF, Kane LW, Cohen S, Levens JH: Immunity in Mumps: I. Experiments with Monkeys (Macacus Mulatta). The Development of Complement-Fixing Antibody Following Infection and Experiments on Immunization by Means of Inactivated Virus and Convalescent Human Serum. J Exp Med, 81:93-117, 1945","DOI":"10.1084\/jem.81.1.93"},{"key":"27","unstructured":"40) Smorodintsev AA, Luzyanina TY, Mikutskaya BA: Data on the Efficiency of Live Mumps Vaccine from Chick Embryo Cell Cultures. Acta Virol, 9:240-247, 1965."},{"key":"28","doi-asserted-by":"crossref","unstructured":"41) Beck M, Welsz-Malecek R, Mesko-Prejac M, Radman V, Juzbasic M, Rajninger-Miholic M, Prislin-Musklic M, Dobrovsak-Sourek V, Smerdel S, Stainer DW: Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J Biol Stand, 17: 85-90, 1989.","DOI":"10.1016\/0092-1157(89)90031-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"42) Buynak EB, Hilleman MR: Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med, 123:768-775, 1966.","DOI":"10.3181\/00379727-123-31599"},{"key":"30","doi-asserted-by":"crossref","unstructured":"43) Odisseev H, Gacheva N: Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria. Vaccine, 12:1251-1254, 1994.","DOI":"10.1016\/S0264-410X(94)80047-4"},{"key":"31","unstructured":"44) Gluck R, Hoskins JM, Wegmann A, Just M, Germanier R: Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Dev Biol Stand, 65:29-35, 1986."},{"key":"32","doi-asserted-by":"crossref","unstructured":"45) Pons C, Pelayo T, Pachon I, Galmes A, Gonzalez L, Sanchez C, Martinez F: Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy. Euro Surveill, 5:80-84, 2000.","DOI":"10.2807\/esm.05.07.00014-en"},{"key":"33","doi-asserted-by":"crossref","unstructured":"46) Ong G, Goh KT, Ma S, Chew SK: Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect, 51:294-298, 2005.","DOI":"10.1016\/j.jinf.2004.10.001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"47) Germann D, Strohle A, Eggenberger K, Steiner CA, Matter L: An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis, 28:235-238, 1996.","DOI":"10.3109\/00365549609027163"},{"key":"35","doi-asserted-by":"crossref","unstructured":"48) Sassani A, Mirchamsy H, Shafyi A, Ahourai P, Razavi J, Gholami MR, Mohammadi A, Ezzi A, Rahmani M, Fateh G, et al.: Development of a new live attenuated mumps virus vaccine in human diploid cells. Biologicals, 19:203-211, 1991.","DOI":"10.1016\/1045-1056(91)90036-J"},{"key":"36","doi-asserted-by":"crossref","unstructured":"49) Feiterna-Sperling C, Bronnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G: Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children. Pediatr Infect Dis J, 24:1083-1088, 2005.","DOI":"10.1097\/01.inf.0000183746.92218.f9"},{"key":"37","unstructured":"50) Hosai H, Yamanishi K, Ueda S, Minekawa Y, Ogino T: Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method. Biken J, 13: 121-126, 1970."},{"key":"38","unstructured":"52) Sasaki K, Higashihara M, Inoue K, Igarashi Y, Makino S: Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino ''wild'' strain of mumps virus. Kitasato Arch Exp Med, 49: 43-52, 1976."},{"key":"39","doi-asserted-by":"crossref","unstructured":"57) Sawada H, Yano S, Oka Y, Togashi T: Transmission of Urabe mumps vaccine between siblings. Lancet, 342: 371, 1993.","DOI":"10.1016\/0140-6736(93)91515-N"},{"key":"40","doi-asserted-by":"crossref","unstructured":"59) Fahlgren K: Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella? Scand J Soc Med, 16:129-135, 1988.","DOI":"10.1177\/140349488801600301"},{"key":"41","unstructured":"60) Galazka AM, Robertson SE, Kraigher A: Mumps and mumps vaccine: a global review. Bull World Health Organ, 77:3-14, 1999."},{"key":"42","doi-asserted-by":"crossref","unstructured":"61) Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM: Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis, 45:459-466, 2007.","DOI":"10.1086\/520028"},{"key":"43","unstructured":"62) World Health Organization (WHO): Mumps virus vaccines. Wkly Epidemiol Rec, 82:51-60, 2007."},{"key":"44","unstructured":"63) Centers for Disease Control and Prevention (CDC): Mumps epidemic--Iowa, 2006. MMWR Morb Mortal Wkly Rep, 55:366-368, 2006."},{"key":"45","unstructured":"64) Centers for Disease Control and Prevention (CDC): Mumps epidemic--United kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep, 55:173-175, 2006."},{"key":"46","doi-asserted-by":"crossref","unstructured":"65) Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF: Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ, 175:483-488, 2006.","DOI":"10.1503\/cmaj.060660"},{"key":"47","doi-asserted-by":"crossref","unstructured":"66) Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, Blog D: Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010. Hum Vaccin Immunother, 10:1373-1381, 2014.","DOI":"10.4161\/hv.28389"},{"key":"48","doi-asserted-by":"crossref","unstructured":"67) Park SH: Resurgence of mumps in Korea. Infect Chemother, 47:1-11, 2015.","DOI":"10.3947\/ic.2015.47.1.1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"68) Ramanathan R, Voigt E A, Kennedy RB, Poland GA: Knowledge gaps persist and hinder progress in eliminating mumps. Vaccine, 36: 3721-3726,2018.","DOI":"10.1016\/j.vaccine.2018.05.067"},{"key":"50","doi-asserted-by":"crossref","unstructured":"69) Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Zhang C, Ngo L, Rubin S: Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis, 1:ofu094, 2014.","DOI":"10.1093\/ofid\/ofu094"},{"key":"51","doi-asserted-by":"crossref","unstructured":"70) Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, Schulte C, Valure B, Armstrong GL, Gallagher K: Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics, 130:e1567-1574, 2012.","DOI":"10.1542\/peds.2012-0177"},{"key":"52","doi-asserted-by":"crossref","unstructured":"71) Nagai T, Okafuji T, Miyazaki C, Ito Y, Kamada M, Kumagai T, Yuri K, Sakiyama H, Miyata A, Ihara T, et al: A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan. Vaccine, 25:2742-2747, 2007.","DOI":"10.1016\/j.vaccine.2005.11.068"},{"key":"53","doi-asserted-by":"crossref","unstructured":"72) Nakayama T, Onoda K: Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine, 25:570-576, 2007.","DOI":"10.1016\/j.vaccine.2006.05.130"},{"key":"54","doi-asserted-by":"crossref","unstructured":"76) Saika S, Kidokoro M, Kubonoya H, Ito K, Ohkawa T, Aoki A, Nagata N, Suzuki K: Development and biological properties of a new live attenuated mumps vaccine. Comp Immunol Microbiol Infect Dis, 29:89-99, 2006.","DOI":"10.1016\/j.cimid.2006.01.004"},{"key":"55","unstructured":"79) Rubin SA, Plotkin SA (Eds.): Mumps Vaccine. Vaccines 6th ed, Edited by Plotkin SA et al, pp.417-446, Philadelphia, PA: Elsevier,2013.."},{"key":"56","doi-asserted-by":"crossref","unstructured":"80) Somboonthum P, Yoshii H, Okamoto S, Koike M, Gomi Y, Uchiyama Y, Takahashi M, Yamanishi K, Mori Y: Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine, 25:8741-8755, 2007.","DOI":"10.1016\/j.vaccine.2007.10.039"},{"key":"57","doi-asserted-by":"crossref","unstructured":"81) Young KR, Nzula S, Burt DS, Ward BJ: Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin. Vaccine, 32: 238-245, 2014.","DOI":"10.1016\/j.vaccine.2013.11.014"},{"key":"58","doi-asserted-by":"crossref","unstructured":"82) Xu P, Chen Z, Phan S, Pickar A, He B: Immunogenicity of novel mumps vaccine candidates generated by genetic modification. J Virol, 88:2600-2610, 2014.","DOI":"10.1128\/JVI.02778-13"},{"key":"59","doi-asserted-by":"crossref","unstructured":"83) Saika S, Kidokoro M, Aoki A, Ohkawa T: Neurovirulence of mumps virus: intraspinal inoculation test in marmosets. Biologicals, 32:147-152, 2004.","DOI":"10.1016\/j.biologicals.2004.08.003"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/68\/2\/68_125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T03:51:20Z","timestamp":1600487480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/68\/2\/68_125\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.68.125","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}